Important Safety Update from the MHRA
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a summary of letters and notifications issued to healthcare professionals during June 2024. This update covers recent medicine recalls and safety communications affecting clinical practice.
What You Need to Know
The MHRA regularly issues safety alerts and recalls to protect patients and ensure medicines meet required standards. The June 2024 update consolidates multiple notifications in one place, making it easier for clinicians and responders to stay informed about recent regulatory actions.
Key Points
- Multiple medicines and medical devices were subject to safety communications in June 2024
- Recalls and letters address manufacturing, quality, and safety concerns
- Healthcare professionals are advised to review affected product batches and patient records
- Full details of each notification are available on the MHRA website
Recommended Actions
- Review the full MHRA alert to identify medicines relevant to your setting
- Check your current stock against any recalled batch numbers
- Inform relevant team members and update protocols if necessary
- Report any adverse events or concerns to the MHRA Yellow Card scheme
Find Out More
Read the complete June 2024 safety update on the MHRA website.